Comprehensive Oncology · Immunotherapy · Multidisciplinary Care
Colorectal Cancer Treatment in Cuba
Colorectal cancer is one of the most commonly diagnosed cancers worldwide. Cuba's oncology infrastructure offers international patients comprehensive evaluation and multidisciplinary treatment — including surgery, chemotherapy, radiation therapy, and access to immunotherapy agents such as CIMAher (nimotuzumab), an anti-EGFR monoclonal antibody developed by Havana's Center of Molecular Immunology that may be considered for EGFR-expressing tumors. Treatment plans are determined by the medical team based on each patient's clinical condition.
Colorectal Cancer — Treatment Video
Combating Cancer in Cuba — Colorectal Oncology
Visual Guide
Understanding colorectal cancer care in Cuba
See the specialized facilities and patient-centered care that define our colorectal cancer treatment programs.
Specialized Oncology care in Cuba
Comprehensive international patient coordination in Havana
Clinical Evidence & Outcomes
The science behind colorectal cancer treatment in Cuba
Our clinical programs are grounded in peer-reviewed research and coordinated with Cuba's biotechnology institutions. Individual results vary and are confirmed during personalized evaluation.
CIMAher® (nimotuzumab)
EGFR-Expressing Colorectal Tumors
Nimotuzumab is an anti-EGFR monoclonal antibody developed by Cuba's Center of Molecular Immunology. It targets the epidermal growth factor receptor, which is expressed in a subset of colorectal tumors. Eligibility for nimotuzumab depends on EGFR expression status, molecular profiling, and the treating medical team's assessment.
Source: CIM — Center of Molecular Immunology
Multidisciplinary Oncology Model
Comprehensive Colorectal Cancer Care
Cuba's oncology infrastructure provides multimodal treatment for colorectal cancer including surgical resection, systemic chemotherapy, and radiation therapy. Treatment sequencing and intensity are determined by stage, tumor location, molecular markers, and the patient's overall health status.
Source: SMC Salud — Office of Medical Affairs
International Patient Coordination
Comprehensive Support
SMC Salud coordinates the full international patient pathway: medical record review, travel logistics, accommodation, interpretation, treatment scheduling, and post-treatment telemedicine follow-up with the Cuban medical team.
Source: SMC Salud — International Patient Services
Outcomes shown reflect published clinical data and aggregate results. Individual results vary based on diagnosis, disease stage, and overall health, and are confirmed during a personalized medical evaluation. This page is for educational purposes and is not a substitute for professional medical advice.
References & Citations
Clinical content on this page is supported by peer-reviewed research and institutional publications. Individual treatment outcomes vary and are confirmed during personalized medical evaluation.
- 1.
World Health Organization. Colorectal cancer fact sheet. WHO, 2024.
WHO Fact Sheet - 2.
PubMed. Nimotuzumab clinical trials in solid tumors. National Library of Medicine.
PubMed - 3.
Center of Molecular Immunology (CIM). Nimotuzumab (CIMAher) development. Havana, Cuba.
Our Comprehensive Approach
CIMAher® (nimotuzumab)
Anti-EGFR monoclonal antibody developed by CIM, may be considered for EGFR-expressing colorectal tumors subject to medical evaluation.
Comprehensive Evaluation
Oncology review of imaging, biopsy, molecular markers (KRAS, NRAS, BRAF), and prior treatments to build a personalized plan.
Multidisciplinary Tumor Board
Surgical oncologists, medical oncologists, radiation oncologists, and pathologists collaborate on each case.
Surgery & Radiation
Access to surgical oncology (colectomy, rectal resection) and modern radiation therapy planning.
Rehabilitation & Support
Stoma care, nutritional support, psychological counseling, and survivorship programs.
International Patient Care
Full coordination: medical visa, accommodation, interpretation, and 24/7 support in Havana.
Colorectal Cancer — Treatment & Medication
Treatment Options Available in Cuba
Cuba offers comprehensive colorectal cancer treatment including surgery, chemotherapy, radiation therapy, and access to CIMAher® (nimotuzumab) for EGFR-expressing tumors. Treatment is coordinated by a multidisciplinary tumor board. No therapy guarantees a cure, and not every patient will benefit. Treatment suitability is determined after medical evaluation of stage, molecular markers, and overall health.
Treatment suitability is determined after medical evaluation. No therapeutic outcome is guaranteed, and not every patient will benefit. Each case is reviewed individually by the medical team.
Colorectal Cancer — Required Documents
Documents for Medical Evaluation
Providing these documents helps our medical team review your case before you travel. You do not need to send every document to begin — send what you have available.
Biopsy / Pathology Report
Confirmed diagnosis and molecular markers
CT / MRI / PET-CT
Recent staging imaging
Oncology Reports
Specialist consultation and treatment notes
Previous Treatment Records
Surgery, chemotherapy, or radiation history
Current Medications
All medications currently being taken
Recent Laboratory Results
Blood work and tumor markers (CEA, CA 19-9)
Clinical Evidence
Patient Safety
Expert Specialists
International Standards
Frequently Asked Questions
Questions from international patients
Cuba offers comprehensive colorectal cancer treatment including surgical resection, chemotherapy, radiation therapy, and access to immunotherapy agents such as CIMAher (nimotuzumab) for EGFR-expressing tumors. The specific treatment plan is determined by the medical team after evaluation of imaging, biopsy, molecular markers, and the patient's clinical condition.
Find country-specific information, testimonials, and FAQs for your region.
Could This Treatment Be Right for You?
Submit your medical records for review by our medical team. We will assess your case and provide a personalized recommendation. Treatment suitability is determined only after medical evaluation.